Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tim Vervliet
BH4 Domain Peptides Derived From BCL-2/BCL-Xl as Novel Tools Against Acute Pancreatitis
Cell Death Discovery
Cancer Research
Molecular Neuroscience
Immunology
Cell Biology
Cellular
Related publications
BH4 Domain of BCL-2 as a Novel Target for Cancer Therapy
Drug Discovery Today
Drug Discovery
Pharmacology
Mechanism of BCL-2 and BCL-Xl Inhibition of NLRP1 Inflammasome: Loop Domain-Dependent Suppression of ATP Binding and Oligomerization
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Combined Inhibition of Notch Signaling and BCL-2/BCL-xL Results in Synergistic Antimyeloma Effect
Molecular Cancer Therapeutics
Cancer Research
Oncology
The BCL-2 Proteins Noxa and BCL-xL Co-Ordinately Regulate Oxidative Stress-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
BCL-xL in Neuroprotection and Plasticity
Frontiers in Physiology
Physiology
Expression Profile of BCL-2, BCL-XL, and McL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models
Molecular Cancer Therapeutics
Cancer Research
Oncology
Structure-Based Design of Potent BCL-2/BCL-xL Inhibitors With Strong in Vivo Antitumor Activity
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
NH2-terminal BH4 Domain of BCL-2 Is Functional for Heterodimerization With Bax and Inhibition of Apoptosis
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Novel Small-Molecule Inhibitors of BCL-Xl to Treat Lung Cancer
Cancer Research
Cancer Research
Oncology
